We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$7.46B
AUM Growth
+$995M
Cap. Flow
-$777M
Cap. Flow %
-10.41%
Top 10 Hldgs %
43.11%
Holding
851
New
66
Increased
156
Reduced
545
Closed
77

Top Buys

Rank Stock Value
1
OKE icon
Oneok
OKE
+$19.7M
2
NWL icon
Newell Brands
NWL
+$17.6M
3
NEM icon
Newmont
NEM
+$6.91M
4
COTY icon
Coty
COTY
+$5.93M
5
VIR icon
Vir Biotechnology
VIR
+$5.4M

Sector Composition

Rank Sector Weight
1 Energy 52.96%
2 Financials 9.94%
3 Healthcare 5.17%
4 Technology 4.58%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRWD icon
226
Ironwood Pharmaceuticals
IRWD
$611M
$2.24M 0.03%
217,433
-67,667
-24% -$693K
ZYME icon
227
Zymeworks
ZYME
$1.68B
$2.24M 0.03%
62,120
-18,440
-23% -$679K
EWY icon
228
iShares MSCI South Korea ETF
EWY
$21.7B
$2.23M 0.03%
39,037
EPZM
229
DELISTED
Epizyme, Inc
EPZM
$2.21M 0.03%
137,856
-27,719
-17% -$484K
DPZ icon
230
Domino's
DPZ
$11B
$2.21M 0.03%
5,990
-278
-4% -$102K
VSLR
231
DELISTED
VIVINT SOLAR, INC.
VSLR
$2.16M 0.03%
217,967
+39,834
+22% +$287K
ICPT
232
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.15M 0.03%
44,933
-14,578
-24% -$1.13M
TGT icon
233
Target
TGT
$62.1B
$2.13M 0.03%
17,766
+494
+3% +$56.4K
ADAP
234
DELISTED
Adaptimmune Therapeutics
ADAP
$2.06M 0.03%
+205,448
New +$1.29M
HUM icon
235
Humana
HUM
$46.7B
$2.03M 0.03%
5,240
+4,417
+537% +$1.65M
AMD icon
236
Advanced Micro Devices
AMD
$851B
$2.02M 0.03%
38,323
-4,583
-11% -$243K
CHRS icon
237
Coherus Oncology
CHRS
$217M
$2M 0.03%
111,841
-32,448
-22% -$549K
DXCM icon
238
DexCom
DXCM
$27.6B
$1.98M 0.03%
19,524
+4,396
+29% +$393K
ROL icon
239
Rollins
ROL
$18.6B
$1.97M 0.03%
+69,807
New +$1.87M
AMP icon
240
Ameriprise Financial
AMP
$46.8B
$1.96M 0.03%
+13,041
New +$1.67M
ENOV icon
241
Enovis
ENOV
$1.56B
$1.95M 0.03%
40,554
-11,039
-21% -$488K
POWI icon
242
Power Integrations
POWI
$3.54B
$1.94M 0.03%
32,766
-3,860
-11% -$203K
AKCA
243
DELISTED
Akcea Therapeutics Inc
AKCA
$1.9M 0.03%
138,478
-32,242
-19% -$497K
KPTI icon
244
Karyopharm Therapeutics
KPTI
$168M
$1.89M 0.03%
+6,650
New +$1.97M
QNCX icon
245
Quince Therapeutics
QNCX
$17.5M
$1.86M 0.02%
201
-43
-18% -$394K
NDSN icon
246
Nordson
NDSN
$16.5B
$1.82M 0.02%
9,591
+47
+0.5% +$7.97K
HRTX icon
247
Heron Therapeutics
HRTX
$86.3M
$1.82M 0.02%
+123,652
New +$2.03M
SIRI icon
248
SiriusXM
SIRI
$10B
$1.82M 0.02%
30,983
+17,194
+125% +$964K
MIC
249
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$1.81M 0.02%
58,950
+4,503
+8% +$125K
LXP icon
250
LXP Industrial Trust
LXP
$3.53B
$1.8M 0.02%
34,196
-3,345
-9% -$169K

Similar funds

ALPS Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, ALPS Advisors held 851 positions worth $7.46B, up 15% from $6.46B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

ALPS Advisors withdrew a net $777M in Q2 2020, closing 77 positions and reducing 545 holdings. Its most notable exit was EQM Midstream Partners, LP, an estimated $127M position sold in full.

By sector, the portfolio is most concentrated in Energy at 53% of assets, up from 51% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Newell Brands worth $20.3M.

  • ALPS Advisors's largest Q2 2020 buy was Newell Brands: 1,279,812 shares worth $20.3M.
  • ALPS Advisors added most to Oneok in Q2 2020, an estimated $19.7M increase.
  • ALPS Advisors's biggest Q2 2020 reduction was MPLX, cutting an estimated $139M.
  • ALPS Advisors fully exited EQM Midstream Partners, LP in Q2 2020, selling an estimated $127M.
  • ALPS Advisors's ten largest holdings make up 43% of its $7.46B portfolio in Q2 2020.
  • ALPS Advisors opened 66 new positions and closed 77 in Q2 2020.
  • ALPS Advisors's portfolio value rose 15% quarter-over-quarter to $7.46B.

Based on ALPS Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.